Charles River Laboratories
Ellyn Torosian currently serves as the Executive Director of Global CDMO Quality at Charles River Laboratories, a position held since July 2024. Prior to this role, Ellyn was the Site Quality Head at Lonza from May 2023 to December 2024 and the Site Leader at Pfizer for nearly a year. Ellyn's extensive background in quality assurance and operations includes significant roles at Lonza Biologics, Bristol-Myers Squibb, and Genzyme Corporation, spanning from 2002 to 2017. Key responsibilities have included oversight of QA teams, management of batch records, quality assurance for manufacturing operations, and staff development. Ellyn holds a Master of Science in Regulatory Affairs for Drugs, Medical Devices and Biologics from Northeastern University and a Bachelor of Science in Microbiology from the University of New Hampshire.
This person is not in any teams
Charles River Laboratories
15 followers
Charles River Laboratories International, Inc. is an early-stage contract research company. The Company is engaged in laboratory animal medicine and science (research model technologies) and develop a portfolio of discovery and safety assessment services, both good laboratory practice (GLP) and non-GLP, which supports its clients from target identification through non-clinical development. The Company operates in three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Support (Manufacturing). The RMS segment includes Research Models and Research Model Services. The DSA segment includes Discovery Services and Safety Assessment. The Manufacturing segment includes Microbial Solutions, Avian, Biologics and Contract Manufacturing. The Company also provides a suite of products and services to support the Company's clients' manufacturing activities.